Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
1.020
-0.120 (-10.53%)
At close: Mar 9, 2026, 4:00 PM EDT
1.100
+0.080 (7.84%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Clearmind Medicine Balance Sheet
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | 3.92 | 6.57 | 5.43 | 0.13 | 3.71 | Upgrade
|
| Short-Term Investments | 1.66 | 0.29 | 0.09 | 0.19 | - | Upgrade
|
| Cash & Short-Term Investments | 5.59 | 6.86 | 5.51 | 0.32 | 3.71 | Upgrade
|
| Cash Growth | -18.62% | 24.47% | 1609.58% | -91.31% | 1396.58% | Upgrade
|
| Other Receivables | 0.32 | 0.18 | 0.24 | 0.1 | 0.13 | Upgrade
|
| Receivables | 0.32 | 0.18 | 0.24 | 0.1 | 0.13 | Upgrade
|
| Prepaid Expenses | 0.04 | 0.04 | 0.04 | 0.01 | 0.13 | Upgrade
|
| Total Current Assets | 5.95 | 7.09 | 5.79 | 0.43 | 3.97 | Upgrade
|
| Property, Plant & Equipment | 0.02 | 0.05 | 0 | 0.05 | 0.02 | Upgrade
|
| Other Intangible Assets | 0.1 | 0.11 | 0.12 | 0.13 | 0.16 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | 0.2 | - | Upgrade
|
| Other Long-Term Assets | 0.02 | 0.01 | 0.04 | 0.01 | 0.02 | Upgrade
|
| Total Assets | 6.08 | 7.26 | 5.95 | 0.83 | 4.16 | Upgrade
|
| Accounts Payable | 0.68 | 0.53 | 0.62 | 1.4 | 0.28 | Upgrade
|
| Accrued Expenses | 0.06 | 0.05 | 0.04 | 0.21 | 0.01 | Upgrade
|
| Current Portion of Long-Term Debt | 1.76 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 0.02 | 0.04 | - | 0.04 | - | Upgrade
|
| Other Current Liabilities | 2.37 | 3.52 | 4.31 | 0.29 | - | Upgrade
|
| Total Current Liabilities | 4.89 | 4.13 | 4.97 | 1.93 | 0.29 | Upgrade
|
| Long-Term Leases | - | 0.02 | - | - | - | Upgrade
|
| Total Liabilities | 4.89 | 4.15 | 4.97 | 1.93 | 0.29 | Upgrade
|
| Common Stock | 26.4 | 24.17 | 17.13 | 6.71 | 6.38 | Upgrade
|
| Retained Earnings | -27.88 | -24.02 | -18.77 | -10.15 | -3.58 | Upgrade
|
| Comprehensive Income & Other | 2.67 | 2.96 | 2.62 | 2.33 | 1.08 | Upgrade
|
| Shareholders' Equity | 1.19 | 3.11 | 0.98 | -1.11 | 3.87 | Upgrade
|
| Total Liabilities & Equity | 6.08 | 7.26 | 5.95 | 0.83 | 4.16 | Upgrade
|
| Total Debt | 1.78 | 0.05 | - | 0.04 | - | Upgrade
|
| Net Cash (Debt) | 3.81 | 6.81 | 5.51 | 0.28 | 3.71 | Upgrade
|
| Net Cash Growth | -44.10% | 23.51% | 1840.56% | -92.34% | 1396.58% | Upgrade
|
| Net Cash Per Share | 29.95 | 87.87 | - | - | - | Upgrade
|
| Filing Date Shares Outstanding | 0.16 | 0.11 | 0.08 | - | - | Upgrade
|
| Total Common Shares Outstanding | 0.16 | 0.11 | 0.02 | - | - | Upgrade
|
| Working Capital | 1.06 | 2.96 | 0.82 | -1.5 | 3.68 | Upgrade
|
| Book Value Per Share | 7.54 | 29.14 | 64.77 | - | - | Upgrade
|
| Tangible Book Value | 1.1 | 3 | 0.86 | -1.24 | 3.71 | Upgrade
|
| Tangible Book Value Per Share | 6.93 | 28.13 | 56.92 | - | - | Upgrade
|
| Machinery | - | - | - | - | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.